PRKAA2 and metabolic dysfunction-associated steatotic liver disease: Furthermore, three compounds were shown to reduce FFA levels by increasing SIRT1 levels and acting through the AMPK/SIRT1 pathway: Y-mangostin in liver cells in vitro, Apple Polyphenol Extract in HFD-induced NAFLD mice, and liraglutide in HFD-induced diabetic mice.